Scientific Advisory Boards are the main instrument used by the Max Planck Society for the regular evaluation of its research facilities. The Scientific Advisory Board is composed of internationally recognized scientists and it functions as an external advisory committee regarding the scientific performance and administrative development of the Institute. The Scientific Advisory Board evaluates the work of the Institute every three years.
Name | Institution | Country |
|---|---|---|
| Paola Arlotta | Harvard University | USA |
John Briggs | European Molecular Biology Laboratory | Germany |
Colette Dehay | Stem Cell and Brains Research Institute | France |
Richard Durbin | University of Cambridge | UK |
Jean Gruenberg (Chair of the SAB) | University of Geneva | Switzerland |
| Maria Leptin | European Molecular Biology Organization | Germany |
| Helen McNeill | Mount Sinai Hospital | Canada |
| Alexander van Oudenaarden | Hubrecht Institute | Netherlands |
| Rohit Pappu | Washington University in St. Louis | USA |
| Stephen Quake | Stanford University | USA |
| Aurélien Roux | University of Geneva | Switzerland |
| Konrad Sandhoff | Universität Bonn | Germany |
| Jason R. Swedlow | University of Dundee | UK |
| Julie A. Theriot | Stanford University School of Medicine | USA |
The Board of Trustees supports the Institute and fosters links between the public and the MPI-CBG. The members of the Board of Trustees are representatives from the local politics, industry, science, and the media, and they are appointed by the President of the Max Planck Society. The Board meets once a year at the Institute and the Managing Director reports about news, outreach activities and latest developments in general.
| Name | Institution |
|---|---|
Dirk Birgel | |
Heribert Heckschen | |
Joachim Hoof | |
Harald Isemann | |
Matthias Kleiner | |
Michael Madeja | |
Hans-Christian Pape | |
Gerhard Rödel (Chair of the Board of Trustees) | |
| Helmut Schwarz | |
Eva-Maria Stange | |
Klaus Vogel | |
Wilhelm Zörgiebel |